Table 2.

Postoperative PA by Preoperative Assessment Group.

PA metric	G8-fit (n = 43)	G8-vulnerable (n = 76)	p Value	OW diff [95% CI]
(adj: cancer type, sex, disease stage)
Sedentary time (%)	82.7 (78.3-87.5)	87.2 (80.9-92.1)	0.021*	−2.77 pp [−6.17 to +0.87]; p = 0.068
MVPA (%)	4.1 (2.4-6.7)	2.9 (1.6-5.7)	0.045*	+1.27 pp [−0.45 to +3.12]; p = 0.123
Mean acceleration (ENMO, mg)	21.8 (16.9-25.6)	16.8 (11.6-25.4)	0.071	+1.87 mg [−3.47 to +7.71]; p = 0.518
Max MVPA bout duration (min)	6.3 (2.7-12.7)	6.4 (2.6-14.5)	0.836	−3.21 min [−7.64 to +1.00]; p = 0.213
PA metric	Full PF score (n = 53)	Impaired PF score (n = 66)	p Value	OW diff [95% CI]
(adj: age, cancer type, sex, disease stage)
Sedentary time (%)	83.6 (77.9-89.5)	87.3 (80.4-92.7)	0.031*	−0.79 pp [−4.52 to +2.86]; p = 0.574
MVPA (%)	4.1 (2.7-6.8)	2.7 (1.4-5.2)	0.015*	+0.16 pp [−1.87 to +2.08]; p = 0.826
Mean acceleration (ENMO, mg)	21.8 (15.7-26.0)	16.8 (10.7-24.9)	0.044*	−1.62 mg [−10.51 to +5.52]; p = 0.565
Max MVPA bout duration (min)	6.0 (3.2-13.4)	7.5 (1.9-13.6)	0.904	−1.57 min [−8.35 to +6.36]; p = 0.520

Values: median (IQR). p values: Wilcoxon rank-sum.

*p < 0.05.

OW diff: overlap-weighted mean difference (high-function group − low-function group), expressed in percentage points (pp) for sedentary time and MVPA, in mg for mean acceleration, and in minutes for maximum MVPA bout duration; 95% CI: bootstrap percentile (B = 1,000); p: permutation p value (n = 1,000).

adj: adjusted covariates; CI: confidence interval; ENMO: Euclidean Norm Minus One; IQR: interquartile range; mg: milligravity units; MVPA: moderate-to-vigorous physical activity; OW: overlap weighting; PA: physical activity; PF: physical functioning; pp: percentage points.